Physician profile
Michael D Oberle
NPI 1790248953
$10,795.37
in general payments reported to CMS, 2019-2025
34 companies · $1,020 in 2025
The $1,020 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $252 · 2021: $1,119 · 2022: $2,355 · 2023: $2,882 · 2024: $3,167 · 2025: $1,020.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,272 · Travel and Lodging: $925 · Consulting Fee: $872.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,272.22 |
| Travel and Lodging | $925.07 |
| Consulting Fee | $872.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $1,992.58 | 2021-2025 | Titan, Isiris Astent Removal Device |
| Boston Scientific Corporation | $1,963.59 | 2020-2025 | Ams 700, Xpeeda Dsl Fiber, Advance Xp |
| Cook Medical LLC | $1,134.87 | 2021-2024 | Fiber Dust, Litho 150 |
| Bayer Healthcare Pharmaceuticals INC. | $1,041.30 | 2024-2025 | |
| Intuitive Surgical, INC. | $925.07 | 2023 | Da Vinci Surgical System |
| Procept Biorobotics Corporation | $723.61 | 2022-2024 | Aquabeam Robotic System, Aquabeam System |
| Axonics, INC. | $501.16 | 2020-2024 | Axonics, Bulkamid |
| Teleflex LLC | $429.90 | 2023-2024 | Urolift |
| Janssen Biotech, INC. | $175.72 | 2021-2025 | Carvykti, Rybrevant, Akeega |
| Astellas Pharma US INC | $171.54 | 2022-2023 | Xtandi |
| Histosonics, INC. | $170.63 | 2025 | |
| Calyxo, INC. | $167.74 | 2025 | Cvac Aspiration System |
| Sumitomo Pharma America, INC. | $158.93 | 2024-2025 | Orgovyx, Gemtesa |
| Urogen Pharma, INC. | $148.71 | 2023-2025 | Jelmyto |
| Merck Sharp & Dohme LLC | $136.60 | 2023-2024 | Lynparza, Keytruda |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conmed Corporation | $109.82 | 2024 | Conmed Specimen Retrieval, Abc Handpieces, Airseal |
| Progenics Pharmaceuticals, INC. | $100.00 | 2023 | Pylarify |
| Medtronic, INC. | $95.90 | 2024 | Interstim |
| Pfizer INC. | $95.39 | 2024-2025 | |
| Myovant Sciences INC. | $93.85 | 2022 | |
| Endo Pharmaceuticals INC. | $76.09 | 2024 | Xiaflex |
| Palette Life Sciences, INC. | $75.04 | 2023 | |
| Janssen Scientific Affairs, LLC | $42.43 | 2024 | Erleada |
| Blue Earth Diagnostics | $41.62 | 2023 | |
| 180 Medical, INC. | $36.93 | 2024-2025 | Gentlecath Glide |
| Sun Pharmaceutical Industries INC. | $31.79 | 2025 | |
| Becton, Dickinson and Company | $30.72 | 2023 | Bard Urinary Drainage Bag |
| Ambu INC. | $29.67 | 2022 | |
| Tolmar, INC. | $18.69 | 2024 | |
| Dendreon Pharmaceuticals LLC | $17.63 | 2025 | Provenge |
| Ferring Pharmaceuticals INC. | $15.64 | 2025 | Adstiladrin |
| Endo USA, INC. | $14.61 | 2025 | Edex, Xiaflex, Aveed |
| Astrazeneca Pharmaceuticals LP | $14.30 | 2021 | |
| Photocure INC | $13.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Oberle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.